Effects of Alendronate and Calcitonin on Bone Mineral Density in Postmenopausal Osteoporotic Women. An Observational Study

被引：0
|
作者：
Miroslava Hejdova
Vladimir Palicka
Zdenek Kucera
Jiri Vlcek
机构：
[1] Charles University in Prague,Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove
[2] Charles University,Osteocentre, University Hospital
来源：
Pharmacy World and Science | 2005年 / 27卷
关键词：
Alendronate; Bone mineral density; Calcitonin; Czech Republic; Observational study; Postmenopausal osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Alendronate and calcitonin are antiresorptive drugs that were used for the treatment of postmenopausal osteoporosis and were shown to increase bone mineral density (BMD). However, the effect of both drugs in daily clinical practice may differ from that observed in clinical trials.
引用
收藏
页码：149 / 153
页数：4
相关论文
共 50 条
  • [1] Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study
    Hejdova, M
    Palicka, V
    Kucera, Z
    Vlcek, J
    [J]. PHARMACY WORLD & SCIENCE, 2005, 27 (03): : 149 - 153
  • [2] Effects of parathyroid hormone, alendronate, or both on bone density in osteoporotic postmenopausal women.
    Neer, R
    Hayes, A
    Rao, A
    Finkelstein, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S135 - S135
  • [3] Effects of parathyroid hormone, alendronate, or both on bone density in osteoporotic postmenopausal women.
    Neer, R
    Hayes, A
    Wyland, J
    Finkelstein, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S98 - S98
  • [4] Influence of alendronate on bone alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women
    Korzh, OM
    Bondarenko, TI
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S23 - S23
  • [5] Effects of continuous combined HRT and clodronate on bone mineral density in osteoporotic postmenopausal women.
    Tuppurainen, M
    Sandini, L
    Alhava, E
    Jurvelin, J
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S287 - S287
  • [6] The efficacy of Alendronate in postmenopausal osteoporotic women.
    Bernad, M
    Del Campo, T
    Gonzalez, M
    Fernandez, J
    Garces, M
    Martin-Mola, E
    Martinez, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
  • [7] Effects of alendronate therapy on the bone mineral density in postmenopausal women
    Savoca, S
    Nardo, LG
    D'Agosta, S
    Messina, K
    Rosano, T
    Pignatello, R
    Nardo, F
    [J]. RECENT RESEARCH IN GYNECOLOGICAL ENDOCRINOLOGY, 2001, : 231 - 234
  • [8] Secondary hyperparathyroidism decreases the beneficial effect of alendronate on bone mineral density in osteoporotic women.
    Barone, A.
    Pioli, G.
    Girasole, G.
    Giusti, A.
    Pizzonia, M.
    Razzano, M.
    Siccardi, V.
    Palummeri, E.
    Bianchi, G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S111 - S111
  • [9] Alendronate and estrogen effects in postmenopausal women with low bone mineral density
    Bone, HG
    Greenspan, SL
    McKeever, C
    Bell, N
    Davidson, M
    Downs, RW
    Emkey, R
    Meunier, PJ
    Miller, SS
    Mulloy, AL
    Recker, RR
    Weiss, SR
    Heyden, N
    Musliner, T
    Suryawanshi, S
    Yates, AJ
    Lombardi, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02): : 720 - 726
  • [10] Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate
    N. B. Watts
    D. K. Jenkins
    J. M. Visor
    D. C. Casal
    P. Geusens
    [J]. Osteoporosis International, 2001, 12 : 279 - 288
12345